References

  1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009; 114(5):937-5. PubMed | Google Scholar

  2. Gemma Gatta,Jan Maarten van der Zwan, Paolo G. Casali, Sabine Siesling, Angelo Paolo Dei Tos,IanKunkler,RenéeOtter,LisaLicitra,SandraMallone,AndreaTavilla, Annalisa Trama,RiccardoCapocaccia,The RARECARE working group. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer 2011; 47(17): 2493-511. PubMed | Google Scholar

  3. Janet M Torpy, CassioLynm, MA, Richard M. Acute Lymphoblastic Leukemia. JAMA. 2009;301(4):452. PubMed | Google Scholar

  4. Michèle Imbert, Orianne Wagner-Ballon. Place de la biologie moléculaire pour le diagnostic et le suivi des leucémies aiguës. Rev Fr Lab. 2015 ; 471 :29-33. PubMed | Google Scholar

  5. Ben Salah N, El Borgi W, Chelbi A, Ben Lakhal F, Gouider E, AounallahSkhiri H, Hafsia R.Diagnostic de lignée dans les leucémies aiguës : confrontation entre cytologie et immunophénotypage. PatholBiol (Paris). 2014 ; 62(6):345-7. PubMed | Google Scholar

  6. Linabery AM, Ross JA. Trends in childhood cancer incidence in the US, (1992-2004). Cancer. 2008; 112(2):416-432. PubMed | Google Scholar

  7. Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, Kamps WA. Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997: report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006 ; 42(13):2019-36. PubMed | Google Scholar

  8. Parkin DM, Stiller CA, DraperGJ andBieber CA. The international incidence of childhood. Cancer.1988; 42(4):511-520. PubMed | Google Scholar

  9. Greaves MF, Colman SM, Beard ME, Bradstock K, Cabrera ME, Chen PM, Jacobs P, Lam-Po-Tang PR, MacDougall LG, Williams CK, et al. Geographical distribution of acute lymphoblastic leukaemia subtypes: second report of the collaborative group study. Leukemia. 1993; 7(1):27-34. PubMed | Google Scholar

  10. Stiller C, ed. Childhood cancer in Britain: incidence, survival, mortality. Oxford, Oxford UniversityPress. 2007. Google Scholar

  11. Maloney KW, Giller R, Hunger SP. Recent advances in the understanding and treatment of pediatric leukemias. AdvPediatr. 2012;59(1):329-58. PubMed | Google Scholar

  12. Rowe JM, Tallman MS. How I treat acute myeloid leukemia. Blood. 2010; 116(17):3147-56. PubMed | Google Scholar

  13. Schaison G, Baruchel A & Leblanc T.Traitement des leucémies aiguës lymphoïdes de l’enfant. Rev Prat. 1996; 46(1): 48-54. PubMed | Google Scholar

  14. Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Pediatric Oncology. 2008; 55(1):1-20. PubMed | Google Scholar

  15. Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. HematolOncolClin North Am. 2010; 24:35-63. PubMed | Google Scholar

  16. Sophie Bustany, Michelle Malet, VeroniqueSalaun, Dina Naguib, Ghislaine Plessis, Xavier Troussard. La leucémie peu différenciée (MO): aspect hématologique, immunophénotypique, cytogénétique, incidence pronostique expérience de Caen. RevFrLab. 2007; 37(395): 51-58. PubMed | Google Scholar

  17. Marie-Christine Béné, Francis Lacombe. Place de la cytométrie en flux dans le diagnostic et le suivi des leucémies aiguës. Rev Fr Lab. 2015; 35-41. PubMed | Google Scholar